The combination of EGFR5 or TOX hypermethylation showed a sensitivity of 92%, specificity of 92% and accuracy of 93% and the combination of DPYS or TOX hypermethylation showed a sensitivity of 88%, specificity of 96% and accuracy of 91% for detecting breast cancer (Table 3). The gene discussed is CLEC14A; the disease is breast carcinoma.